Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA foreign inspection program "next area of reform," Sen. Mikulski predicts.

This article was originally published in The Tan Sheet

Executive Summary

FDA FOREIGN INSPECTION PROGRAM "NEXT AREA OF REFORM," SEN. MIKULSKI predicted in an address to the Pharmaceutical Research & Manufacturers of America annual meeting in White Sulphur Springs, W.Va. May 11. "I am deeply troubled...that so much [raw material] is coming now from India and China with very poor regulation and very poor oversight," Barbara Mikulski (D-Md.) said. "I'm afraid that there are dangerous situations waiting to happen and it will affect every single one of us," she added. "Let us put our thinking cap on about how we can create a regulatory framework and how to be able to fund it."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088436

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel